LifeMD Competitors

LFMD Stock  USD 2.76  0.09  3.37%   
LifeMD Inc competes with Thrivent High, Morningstar Unconstrained, Via Renewables, T Rowe, and Sitka Gold; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing LifeMD competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of LifeMD to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out LifeMD Correlation with its peers.

LifeMD vs Sycamore Entmt Correlation

Modest diversification

The correlation between LifeMD Inc and SEGI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding LifeMD Inc and SEGI in the same portfolio, assuming nothing else is changed.

Moving together with LifeMD Stock

  0.69EW Edwards Lifesciences CorpPairCorr

Moving against LifeMD Stock

  0.7HYB HOYAPairCorr
  0.44SPEC Inspecs Group plcPairCorr
  0.41DXCM DexCom IncPairCorr
The current year's Return On Equity is expected to grow to 4.16, whereas Return On Tangible Assets are forecasted to decline to (0.40). At present, LifeMD's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 58.8 M, whereas Other Assets are projected to grow to (20.3 T).
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.142.868.01
Details
Intrinsic
Valuation
LowRealHigh
0.224.319.46
Details
Naive
Forecast
LowNextHigh
0.062.938.08
Details
8 Analysts
Consensus
LowTargetHigh
8.429.2510.27
Details

LifeMD Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between LifeMD and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of LifeMD and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of LifeMD Inc does not affect the price movement of the other competitor.

High positive correlations

OSHDFONCSQ
RRTLXMSTSX
RRTLXVIASP
VIASPMSTSX
RRTLXLBHIX
RWAYLVIASP
  

High negative correlations

SEGIVIASP
SEGIRWAYL
SEGIRRTLX
SEGIMSTSX
SITKFVIASP
SITKFRRTLX

Risk-Adjusted Indicators

There is a big difference between LifeMD Stock performing well and LifeMD Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze LifeMD's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ONCSQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
LBHIX  0.12  0.04 (0.52) 0.55  0.00 
 0.24 
 2.15 
MSTSX  0.64  0.25  0.21  60.52  0.17 
 1.45 
 12.34 
VIASP  0.29  0.03 (0.17) 0.80  0.27 
 0.64 
 1.72 
RRTLX  0.27  0.07  0.00  0.30  0.00 
 0.58 
 3.30 
WQTM  1.70  0.10  0.00 (1.07) 2.16 
 3.48 
 9.00 
OSHDF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SITKF  2.61  0.14 (0.01)(0.06) 2.99 
 4.55 
 16.83 
RWAYL  0.12  0.03 (0.49)(0.46) 0.00 
 0.28 
 0.72 
SEGI  10.30  0.62  0.03  0.40  11.27 
 33.33 
 58.33 

LifeMD Competitive Analysis

The better you understand LifeMD competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, LifeMD's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across LifeMD's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
LFMD ONCSQ LBHIX MSTSX VIASP RRTLX WQTM OSHDF SITKF RWAYL
 3.37 
 2.76 
LifeMD
 0.00 
 0.0001 
OncoSec
 0.06 
 17.21 
Thrivent
 0.88 
 11.41 
Morningstar
 0.08 
 25.74 
Via
 0.31 
 13.07 
RRTLX
 2.01 
 26.39 
WisdomTree
 0.00 
 0.04 
Oshidori
 2.82 
 0.73 
Sitka
 0.16 
 25.16 
MSCI
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
EBITDA
Operating Margin
Five Year Return
One Year Return
Beta
Number Of Employees
Three Year Return
Cash Flow From Operations
Total Debt
Bond Positions Weight
Holdings Turnover
Return On Asset
Current Liabilities
Debt To Equity
Short Ratio
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Shares Owned By Insiders
Revenue
Year To Date Return
Working Capital
Profit Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Cash Position Weight
Equity Positions Weight
Shares Outstanding
Annual Yield
Return On Equity
Z Score
Number Of Shares Shorted
Book Value Per Share
Minimum Initial Investment
Total Asset
Target Price
Last Dividend Paid
Earnings Per Share
Ten Year Return
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

LifeMD Competition Performance Charts

Five steps to successful analysis of LifeMD Competition

LifeMD's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by LifeMD Inc in relation to its competition. LifeMD's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of LifeMD in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact LifeMD's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to LifeMD Inc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your LifeMD position

In addition to having LifeMD in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Management Thematic Idea Now

Management
Management Theme
Companies providing management services to businesses. The Management theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Management Theme or any other thematic opportunities.
View All  Next Launch
When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:
Check out LifeMD Correlation with its peers.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Will Health Care Equipment & Supplies sector continue expanding? Could LifeMD diversify its offerings? Factors like these will boost the valuation of LifeMD. Expected growth trajectory for LifeMD significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every LifeMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.25)
Revenue Per Share
5.686
Quarterly Revenue Growth
0.13
Return On Assets
(0.03)
Return On Equity
(22.43)
LifeMD Inc's market price often diverges from its book value, the accounting figure shown on LifeMD's balance sheet. Smart investors calculate LifeMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since LifeMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that LifeMD's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LifeMD represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.